scholarly journals MRI validation of Post-Prostatectomy Radiotherapy Contouring

2019 ◽  
pp. 01-09
Author(s):  
Mo Manji ◽  
Juanita Crook ◽  
Leigh Bartha ◽  
Rasika R ajapakshe
Keyword(s):  
Adjuvant Radiotherapy ◽  
Local Relapse ◽  
Anatomic Structure ◽  
Prostate Bed ◽  
Marked Variability ◽  
Treatment Volume ◽  
Frequent Site ◽  
Inferior Border ◽  
Penile Bulb ◽  
Geographic Miss

Introduction: Level One Evidence has established the indications for, and importance of, adjuvant radiotherapy following radical prostatectomy. Several guidelines have addressed delineation of the prostate bed but with variable specification of the inferior border relative to the penile bulb or to the first CT slice distal to visible urine in the bladder neck. This work determines the correlation between the caudal aspect of the anastomosis shown by the tip of the urethrogram cone and MRI anatomy. Materials and Methods : Sixteen patients receiving adjuvant radiotherapy following prostatectomy underwent diagnostic MRI in addition to planning CT with Urethrogram. The CT Reference Slice, tip of urethrogram cone and superior aspect of penile bulb were delineated. Results: MRI clearly demonstrates the penile bulb but not the anastomosis. In these 16 patients, the tip of the urethrogram cone was a median 3.9 mm cranial to the penile bulb (range 0-10.3 mm). Conclusion: We show marked variability in the distance between penile bulb and the tip of the urethrogram cone. In all sixteen patients, placing the inferior border of the CTV 15mm cranial to the penile bulb would have failed to treat the caudal aspect of the anastomosis, a frequent site of local relapse, that cannot be reliably landmarked by any other anatomic structure. Individualizing the treatment volume to patient anatomy is the only way to ensure consistent coverage without treating a larger than necessary volume in many patients. We recommend the use of planning urethrogram to minimize the potential for geographic miss.

Adjuvant radiotherapy plus systemic chemotherapy in resected head and neck mucosal melanoma.

2021 ◽  
Vol 39 (15_suppl) ◽  
pp. e18042-e18042
Author(s):  
Rong Duan ◽  
Bixia Tang ◽  
Zhihong Chi ◽  
Chuanliang Cui ◽  
Bin Lian ◽  
...  
Keyword(s):  
Prognostic Factors ◽  
Head And Neck ◽  
Distant Metastasis ◽  
Adjuvant Radiotherapy ◽  
Postoperative Radiotherapy ◽  
Local Relapse ◽  
Mucosal Melanoma ◽  
Uicc Stage ◽  
Free Survival ◽  
Cox Analysis

e18042 Background: The median over survival (OS) of resected head and neck mucosal melanoma (HNMM) is 49.0 months. About 65% of patients experience local recurrence or distant metastasis after surgery. Therefore, adjuvant therapy is critical to improve the poor prognosis. Methods: Data regarding HNMMs with radical surgery (stage III-IVa, AJCC HNMM 8th version) between September 1, 2006 and February 28, 2020 at Peking University Cancer Hospital was collected retrospectively. Postoperative radiotherapy was usually prescribed as GTV 60-70Gy/CTV 60Gy/30f. Patients were divided into four groups by the adjuvant regimens: radiotherapy+chemotherapy (RC), chemotherapy (C), radiotherapy (R) and observation (O). Results: In total, 368 patients were enrolled, including 104 RC,114 C, 53 R, 97 O, respectively. After median follow-up of 63.9 mo (range: 0.9-146.7), the median local relapse-free survival (LRFS) was 10.1 mo (95%CI: 6.7-13.6) in the O group, as compared with 65.9 mo (95%CI: 31.7-100.1, P＜0.001) in the R group, 75.6 mo (95%CI: 50.1-101.0, P＜0.001) in the C group, and 84.6 mo (95%CI: 48.5-120.8, P＜0.001) in the RC group. The median distant metastasis-free survival (DMFS) was 13.7 mo (95%CI: 8.0-19.5) in the O group, 15.3 mo (95%CI: 8.7-21.9, P = 0.898) in the R group, as compared with 25.7 mo (95%CI: 14.6-36.8, P = 0.001) in the C group, 49.3 mo (95%CI: 32.6-66.0, P＜0.001) in the RC group. Estimated OS was 36.4 mo (95%CI: 24.0-48.8) in the O group, as compared with 30.8 mo (95%CI: 23.0-38.6, P = 0.733) in the R group, 40.8 mo (95%CI: 34.8-46.8, P = 0.289) in the C group, 58.2 mp (95%CI: 36.4-79.9, P = 0.002) in the RC group. Primary location, age, gender, UICC staging and adjuvant regimens were included for multivariate Cox analysis. With regard to OS, UICC stage and RC were the prognostic factors. With regard to DMFS, UICC stage, RC and C were the prognostic factors. With regard to LRFS, UICC stage, RC, R, C were the prognostic factors. Conclusions: It is the largest study on the role of adjuvant radiotherapy and chemotherapy on HNMM till now. The results demonstrate that postoperative radiotherapy improves LRFS but has no impact on DMFS, while adjuvant radiotherapy plus chemotherapy prolongs OS. It further validates the clinical practice of UICC stage of HNMM, which might shed lights on the study of the whole mucosal melanoma.

scholarly journals Successful use of three-dimensional conformal radiotherapy as adjuvant treatment for alveolar soft part sarcoma. A case report

2021 ◽  
Vol 70 (1) ◽  
Author(s):  
Eliana Evelina Ocolotobiche ◽  
Esteban Pérez-Duhalde ◽  
Alba Mabel Güerci
Keyword(s):  
Adjuvant Radiotherapy ◽  
Soft Part ◽  
Three Dimensional ◽  
Conformal Radiotherapy ◽  
Metastatic Tumor ◽  
Local Relapse ◽  
Alveolar Soft Part Sarcoma ◽  
Genetic Characteristics ◽  
Three Dimensional Conformal Radiotherapy ◽  
The Right

Introduction: Alveolar soft part sarcoma is a very rare and aggressive type of sarcoma. Although its histology and genetic characteristics have been identified, the benefits of adjuvant radiotherapy for its treatment are still being studied. Case presentation: In November 2007, a 21-year-old woman presented with a primary tumor in the right thigh, with histological and immunohistochemical confirmation of an alveolar soft part sarcoma, which was totally resected in December 2007. Also, the large size of the mass suggested an unfavorable evolution. Two years after the first surgery, two metastatic tumors were detected in the right lung, which were completely resected separately. Two years later, the patient had two independent relapse events, five months apart: a mass in the right tight, and a metastatic tumor in the adrenal gland together with relapse in the tight. All tumors were successfully resected. In June 2014, after the last local relapse, adjuvant radiotherapy was started because of the risk of thigh amputation. At the end of treatment, the patient’s general condition was good. Currently, at age 34, the patient is monitored through periodic evaluations, showing disease regression and stabilization. Conclusions: Currently, it is known that radiation not only produces cytotoxic effects on the target region, but also induces an immune system-mediated systemic response with potential antimetastatic properties. The emerging radiobiological paradigms should be considered, particularly since they could explain some encouraging and unexpected results such as those described in this case.

scholarly journals Spine stereotactic radiosurgery for metastatic sarcoma: patterns of failure and radiation treatment volume considerations

2017 ◽  
Vol 27 (3) ◽  
pp. 303-311 ◽  
Author(s):  
Andrew J. Bishop ◽  
Randa Tao ◽  
B. Ashleigh Guadagnolo ◽  
Pamela K. Allen ◽  
Neal C. Rebueno ◽  
...  
Keyword(s):  
Stereotactic Radiosurgery ◽  
Soft Tissues ◽  
Radiation Treatment ◽  
Spinal Metastases ◽  
Local Relapse ◽  
Tumor Control ◽  
High Dose ◽  
Patterns Of Failure ◽  
Local Recurrences ◽  
Treatment Volume

OBJECTIVEGiven the relatively lower radiosensitivity of sarcomas and the locally infiltrative patterns of spread, the authors sought to investigate spine stereotactic radiosurgery (SSRS) outcomes for metastatic sarcomas and to analyze patterns of failure.METHODSThe records of 48 patients with 66 sarcoma spinal metastases consecutively treated with SSRS between 2002 and 2013 were reviewed. The Kaplan-Meier method was used to estimate rates of overall survival (OS) and local control (LC). Local recurrences were categorized as occurring infield (within the 95% isodose line [IDL]), marginally (between the 20% and 95% IDLs), or out of field.RESULTSMedian follow-up time was 19 months (range 1–121 months), and median age was 53 years (range 17–85 years). The most commonly treated histology was leiomyosarcoma (42%). Approximately two-thirds of the patients were treated with definitive SSRS (44 [67%]) versus postoperatively (22 [33%]). The actuarial 1-year OS and LC rates were 67% and 81%, respectively. Eighteen patients had a local relapse, which was more significantly associated with postoperative SSRS (p = 0.04). On multivariate modeling, receipt of postoperative SSRS neared significance for poorer LC (p = 0.06, subhazard ratio [SHR] 2.33), while only 2 covariates emerged as significantly correlated with LC: 1) biological equivalent dose (BED) > 48 Gy (vs BED ≤ 48 Gy, p = 0.006, SHR 0.21) and 2) single vertebral body involvement (vs multiple bodies, p = 0.03, SHR 0.27). Of the 18 local recurrences, 14 (78%) occurred at the margin, and while the majority of these cases relapsed within the epidural space, 4 relapsed within the paraspinal soft tissue. In addition, 1 relapse occurred out of field. Finally, the most common acute toxicity was fatigue (15 cases), with few late toxicities (4 insufficiency fractures, 3 neuropathies).CONCLUSIONSFor metastatic sarcomas, SSRS provides durable tumor control with minimal toxicity. High-dose single-fraction regimens offer optimal LC, and given the infiltrative nature of sarcomas, when paraspinal soft tissues are involved, larger treatment volumes may be warranted.

Effect of incorporation of preoperative CT scan on bladder doses and irradiated volume in postprostatectomy radiation therapy (pPRT).

2017 ◽  
Vol 35 (6_suppl) ◽  
pp. e561-e561
Author(s):  
Mani Akhtari ◽  
Denley Ming Kee Yuan ◽  
Eugene C. Endres ◽  
Bao Minh Tran ◽  
Todd A. Swanson
Keyword(s):  
Radiation Therapy ◽  
Ct Scan ◽  
Radiation Therapy Oncology Group ◽  
Progression Free Survival ◽  
Target Volume ◽  
Consensus Definition ◽  
Prostate Bed ◽  
Patients At Risk ◽  
Preoperative Ct ◽  
Penile Bulb

e561 Background: pPRT increases local control, biochemical progression free survival, and even overall survival in patients with adverse features undergoing prostatectomy. The Radiation Therapy Oncology Group (RTOG) consensus definition of the clinical target volume (CTV) in 2010 was based on patterns of failure and anatomy without consideration of pre-operative imaging. This results in large volumes of bladder in the treatment field. Our study evaluates whether incorporation of pre-operative prostate volume can reduce the post-operative CTV and minimize dose to adjacent normal tissue. Methods: We reviewed records of all patients with available pre-operative pelvic CT scans treated at our institution with pPRT. The pre-operative CT scan was fused to the simulation CT. Post-operative CTV (CTV1) was delineated based on RTOG guidelines. A separate CTV (CTV2) was constructed, based on the intact prostate and proximal seminal vesicles. Plans were constructed for each CTV and doses to rectum, bladder, and penile bulb calculated, as well as concordance between the two CTVs and planning target volumes (PTVs). Paired student’s t-test was used to calculate difference between doses in the two different plans. Results: 10 patients’ plans were analyzed. Dosimetric parameters are shown in table 1. Volume of the bladder receiving 65 Gy or higher (V65) was significantly higher in CTV1. As would be expected, there were no significant differences in dose to either the rectum or penile bulb. Additionally, there was on average only 39% overlap between the CTVs and 60% between the PTVs in the two plans. Conclusions: Utilization of the pre-operative pelvic CT scan can aid in more accurate delineation of the CTV/PTV in prostate bed radiation therapy and decrease the bladder dose. As many patients at risk for pPRT have had this imaging performed preoperatively, in accordance with guidelines, incorporation of this data appears prudent. These findings need to be validated in a larger cohort. [Table: see text]

Adjuvant radiotherapy in stage I seminoma: Is there a role for further reduction of treatment volume?

2005 ◽  
Vol 44 (2) ◽  
pp. 142-148 ◽  
Author(s):  
Frank Bruns ◽  
Michael Bremer ◽  
Andreas Meyer ◽  
Johann H. Karstens
Keyword(s):  
Adjuvant Radiotherapy ◽  
Stage I ◽  
Treatment Volume ◽  
Stage I Seminoma

Clinical Update: Understanding Causation: An Example Using Carpal Tunnel Syndrome

2007 ◽  
Vol 12 (6) ◽  
pp. 5-8 ◽  
Author(s):  
J. Mark Melhorn
Keyword(s):  
Risk Factors ◽  
Carpal Tunnel Syndrome ◽  
Carpal Tunnel ◽  
Legal Responsibility ◽  
Medical Evidence ◽  
Anatomic Structure ◽  
Legal Professionals ◽  
Compensation Systems ◽  
Tunnel Syndrome ◽  
Four Levels

Abstract Medical evidence is drawn from observation, is multifactorial, and relies on the laws of probability rather than a single cause, but, in law, finding causation between a wrongful act and harm is essential to the attribution of legal responsibility. These different perspectives often result in dissatisfaction for litigants, uncertainty for judges, and friction between health care and legal professionals. Carpal tunnel syndrome (CTS) provides an example: Popular notions suggest that CTS results from occupational arm or hand use, but medical factors range from congenital or acquired anatomic structure, age, sex, and body mass index, and perhaps also involving hormonal disorders, diabetes, pregnancy, and others. The law separately considers two separate components of causation: cause in fact (a cause-and-effect relationship exists) and proximate or legal cause (two events are so closely related that liability can be attached to the first event). Workers’ compensation systems are a genuine, no-fault form of insurance, and evaluators should be aware of the relevant thresholds and legal definitions for the jurisdiction in which they provide an opinion. The AMA Guides to the Evaluation of Permanent Impairment contains a large number of specific references and outlines the methodology to evaluate CTS, including both occupational and nonoccupational risk factors and assigning one of four levels of evidence that supports the conclusion.

Sign in / Sign up

Export Citation Format

Share Document